A retrospective study analysing reactogenicity after mRNA COVID-19 vaccines
Latest Information Update: 22 Nov 2021
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 22 Nov 2021 New trial record
- 16 Oct 2021 Results published in the Vaccine